The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127803701 12780370 1 I 20160401 20160920 20160926 20160926 EXP PHEH2016US024185 NOVARTIS 73.01 YR F Y 0.00000 20160926 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127803701 12780370 1 PS FEMARA LETROZOLE 1 Oral 1 DF, QD U 20726 1 DF TABLET QD
127803701 12780370 2 SS PALBOCICLIB PALBOCICLIB 1 Oral 125 MG, QD (ONCE A DAILY FOR 21 DAYS FOLLOWED BY A 7 DAY REST PERIOD TO COMPLETE A 28 DAYS CYCLE) Y 0 125 MG QD
127803701 12780370 3 SS PALBOCICLIB PALBOCICLIB 1 Oral 75 MG, QD (ONCE A DAILY FOR 21 DAYS FOLLOWED BY A 7 DAY REST PERIOD TO COMPLETE A 28 DAYS CYCLE) Y 0 75 MG QD
127803701 12780370 4 C ADVAIR DISKUS FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Respiratory (inhalation) (DOSE: 250 TO 50 MCG), PRN U 0
127803701 12780370 5 C PREDNISONE. PREDNISONE 1 Oral 20 MG, QD (AD NEEDED) U 0 20 MG TABLET QD
127803701 12780370 6 C ALBUTEROL. ALBUTEROL 1 Respiratory (inhalation) 90 UG, PRN U 0 90 UG AEROSOL
127803701 12780370 7 C AMITRIPTYLINE AMITRIPTYLINE 1 Oral 25 MG, QD (AS NEEDED) U 0 25 MG TABLET QD
127803701 12780370 8 C ALBUTEROL SULFATE. ALBUTEROL SULFATE 1 Respiratory (inhalation) 5 MG/ML, PRN U 0 SOLUTION
127803701 12780370 9 C AZITHROMYCIN ANHYDROUS. AZITHROMYCIN ANHYDROUS 1 Oral 1 DF, QD (AS NEEDED) U 0 1 DF TABLET QD
127803701 12780370 10 C VITAMIN D3 CHOLECALCIFEROL 1 Oral 1 DF, QD U 0 1 DF CAPSULE QD
127803701 12780370 11 C CALCIUM CITRATE CALCIUM CITRATE 1 Oral 1 DF, QD U 0 1 DF TABLET QD
127803701 12780370 12 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 1 DF, QD U 0 1 DF CAPSULE QD
127803701 12780370 13 C DECADRON DEXAMETHASONE 1 Oral 12 MG, ONCE/SINGLE D 0 12 MG 1X
127803701 12780370 14 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Oral 16 MG, ONCE/SINGLE D 0 16 MG 1X
127803701 12780370 15 C ATIVAN LORAZEPAM 1 Oral 0.5 MG, ONCE/SINGLE D 0 .5 MG 1X
127803701 12780370 16 C TRIAMCINOLONE ACETONIDE. TRIAMCINOLONE ACETONIDE 1 Topical (DOSE: 1 TOPICAL APPLICATION), BID U 0 CREAM BID
127803701 12780370 17 C CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 1060 MG, ONCE/SINGLE D 0 1060 MG 1X
127803701 12780370 18 C ADRIAMYCIN DOXORUBICIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) 100 MG, ONCE/SINGLE D 0 100 MG 1X
127803701 12780370 19 C EMEND APREPITANT 1 Intravenous (not otherwise specified) 150 MG, ONCE/SINGLE D 0 150 MG 1X
127803701 12780370 20 C NORMAL SALINE SODIUM CHLORIDE 1 Intravenous (not otherwise specified) 250 ML, ONCE/SINGLE D 0 250 ML 1X
127803701 12780370 21 C ZOMETA ZOLEDRONIC ACID 1 Intravenous (not otherwise specified) 4 MG, ONCE/SINGLE D 0 4 MG 1X
127803701 12780370 22 C OMEPRAZOLE. OMEPRAZOLE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127803701 12780370 1 Breast cancer metastatic
127803701 12780370 2 Breast cancer metastatic
127803701 12780370 4 Asthma
127803701 12780370 5 Asthma
127803701 12780370 6 Asthma
127803701 12780370 7 Product used for unknown indication
127803701 12780370 8 Asthma
127803701 12780370 9 Product used for unknown indication
127803701 12780370 10 Product used for unknown indication
127803701 12780370 11 Product used for unknown indication
127803701 12780370 12 Product used for unknown indication
127803701 12780370 13 Product used for unknown indication
127803701 12780370 14 Product used for unknown indication
127803701 12780370 15 Product used for unknown indication
127803701 12780370 16 Product used for unknown indication
127803701 12780370 17 Product used for unknown indication
127803701 12780370 18 Product used for unknown indication
127803701 12780370 19 Product used for unknown indication
127803701 12780370 20 Product used for unknown indication
127803701 12780370 21 Product used for unknown indication
127803701 12780370 22 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
127803701 12780370 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127803701 12780370 Arthralgia
127803701 12780370 Bone pain
127803701 12780370 Fatigue
127803701 12780370 Neutropenia Neutropenia
127803701 12780370 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127803701 12780370 1 20151013 0
127803701 12780370 2 20151111 0
127803701 12780370 13 20150915 0
127803701 12780370 14 20150915 0
127803701 12780370 15 20150915 0
127803701 12780370 16 20150915 0
127803701 12780370 17 20150915 0
127803701 12780370 18 20150915 0
127803701 12780370 19 20150915 0
127803701 12780370 20 20151006 0
127803701 12780370 21 20151006 0